期刊文献+

Intestinal microbiota and type 2 diabetes:from mechanism insights to therapeutic perspective 被引量:26

Intestinal microbiota and type 2 diabetes:from mechanism insights to therapeutic perspective
下载PDF
导出
摘要 The incidence of type 2 diabetes(T2DM)is rapidly increasing worldwide.However,the pathogenesis of T2DM has not yet been well explained.Recent evidence suggests that the intestinal microbiota composition is associated with obesity and T2DM.In this review,we provide an overview about the mechanisms underlying the role of intestinal microbiota in the pathogenesis of T2DM.There is clear evidence that the intestinal microbiota influences the host through its effect on body weight,bile acid metabolism,proinflammatory activity and insulin resistance,and modulation of gut hormones.Modulating gut microbiota with the use of probiotics,prebiotics,antibiotics,and fecal microbiota transplantation may have benefits for improvement in glucose metabolism and insulin resistance in the host.Further studies are required to increase our understanding of the complex interplay between intestinal microbiota and the host with T2DM.Further studies may be able to boost the development of new effective therapeutic approaches for T2DM. The incidence of type 2 diabetes (T2DM) is rapidly increasing worldwide. However, the pathogenesis of T2DM has not yet been well explained. Recent evidence suggests that the intestinal microbiota composition is associated with obesity and T2DM. In this review, we provide an overview about the mechanisms underlying the role of intestinal microbiota in the pathogenesis of T2DM. There is clear evidence that the intestinal microbiota influences the host through its effect on body weight, bile acid metabolism, proinflammatory activity and insulin resistance, and modulation of gut hormones. Modulating gut microbiota with the use of probiotics, prebiotics, antibiotics, and fecal microbiota transplantation may have benefits for improvement in glucose metabolism and insulin resistance in the host. Further studies are required to increase our understanding of the complex interplay between intestinal microbiota and the host with T2DM. Further studies may be able to boost the development of new effective therapeutic approaches for T2DM.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第47期17737-17745,共9页 世界胃肠病学杂志(英文版)
关键词 INTESTINAL MICROBIOTA Type 2 DIABETES Body WEIGHT Intestinal microbiota Type 2 diabetes Body weight Bile-acid metabolism Insulin resistance Intestinal microbiota modulation
  • 相关文献

参考文献8

  • 1Gábor Firneisz.Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?[J].World Journal of Gastroenterology,2014,20(27):9072-9089. 被引量:23
  • 2Kouichi Miura,Hirohide Ohnishi.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2014,20(23):7381-7391. 被引量:80
  • 3Yan-Yan Ma,Lin Li,Chao-Hui Yu,Zhe Shen,Li-Hua Chen,You-Ming Li.Effects of probiotics on nonalcoholic fatty liver disease:A meta-analysis[J].World Journal of Gastroenterology,2013,19(40):6911-6918. 被引量:30
  • 4F. Horton,J. Wright,L. Smith,P. J. Hinton,M. D. Robertson.Increased intestinal permeability to oral chromium (<sup>51</sup>Cr) ‐ EDTA in human Type 2 diabetes[J].Diabet Med.2014(5)
  • 5Marlene Wewalka,Mary-Elizabeth Patti,Corinne Barbato,Sander M. Houten,Allison B. Goldfine.Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin[J].The Journal of Clinical Endocrinology & Metabolism.2014(4)
  • 6K.B.M. Saiful Islam,Satoru Fukiya,Masahito Hagio,Nobuyuki Fujii,Satoshi Ishizuka,Tadasuke Ooka,Yoshitoshi Ogura,Tetsuya Hayashi,Atsushi Yokota.Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats[J].Gastroenterology.2011(5)
  • 7Vijay Prabha,Manju Ohri.Review: Bacterial transformations of bile acids[J].World Journal of Microbiology and Biotechnology.2006(2)
  • 8RACHEL L.BATTERHAM,STEPHEN R.BLOOM.The Gut Hormone Peptide YY Regulates Appetite[J].Annals of the New York Academy of Sciences.2006(1)

二级参考文献47

  • 1Grace Lai-Hung Wong.Transient elastography: Kill two birds with one stone?[J].World Journal of Hepatology,2013,5(5):264-274. 被引量:18
  • 2Ya-Ping Zhang Xi-Xian Yao Xia Zhao.Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells[J].World Journal of Gastroenterology,2006,12(9):1392-1396. 被引量:22
  • 3G. Musso,M. Cassader,F. Rosina,R. Gambino.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials[J]. Diabetologia . 2012 (4)
  • 4Michele Malaguarnera,Marco Vacante,Tijana Antic,Maria Giordano,Giuseppe Chisari,Rosaria Acquaviva,Silvana Mastrojeni,Giulia Malaguarnera,Antonio Mistretta,Giovanni Volti,Fabio Galvano.Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis[J]. Digestive Diseases and Sciences . 2012 (2)
  • 5Pietro Vajro,Claudia Mandato,Maria Rosaria Licenziati,Adriana Franzese,Dino Franco Vitale,Selvaggia Lenta,Maria Caropreso,Gianfranco Vallone,Rosaria Meli.Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease[J]. Journal of Pediatric Gastroenterology and Nutrition . 2011 (6)
  • 6Mariano Malaguarnera,Maria Pia Gargante,Giulia Malaguarnera,Mario Salmeri,Silvana Mastrojeni,Liborio Rampello,Giovanni Pennisi,Giovanni Li Volti,Fabio Galvano.Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy[J]. European Journal of Gastroenterology & Hepatology . 2010 (2)
  • 7LiviaDe Fraia Pinto,Cecília MelletiCompri,Jo?o VictorFornari,WaldemarBartchewsky,Dennys EduardoCintra,MiriamTrevisan,PatríciaDe Oliveira Carvalho,Marcelo LimaRibeiro,Licio A.Velloso,Mario J.Saad,JoséPedrazzoli,AlessandraGambero.The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high‐fat diet in mice[J]. Liver International . 2010 (4)
  • 8Mary E. Rinella,Sean Koppe,Elizabeth M. Brunt,Marc Elias,Jeanne Gottstein,Richard M. Green.563 Pentoxifylline Improves ALT and Histology in Patients with NASH, a Double Blind Placebo Controlled Trial[J]. Gastroenterology . 2009 (5)
  • 9Piotr Socha,Andrea Horvath,Pietro Vajro,Piotr Dziechciarz,Anil Dhawan,Hania Szajewska.Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review[J]. Journal of Pediatric Gastroenterology and Nutrition . 2009 (5)
  • 10P. D. Cani,A. M. Neyrinck,F. Fava,C. Knauf,R. G. Burcelin,K. M. Tuohy,G. R. Gibson,N. M. Delzenne.Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia[J]. Diabetologia . 2007 (11)

共引文献130

同被引文献158

引证文献26

二级引证文献168

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部